search

While the COVID-19 pandemic has caused a sanitary crisis around the world, pharmaceutical companies are going full steam ahead to develop solutions for diagnosing, treating and eventually curing the disease. The FTD SARS-CoV-2 Assay test kit presented by Siemens Healthineers on 2 April 2020 uses the same workflow as the company’s other FTD Respiratory Disease kits. It can be run in laboratories simultaneously with FTD Respiratory Pathogens 21, a molecular syndromic testing panel that identifies 21 different upper respiratory pathogens.

“With this molecular diagnostic assay, we want to make a contribution to fight the current COVID-19 global pandemic by delivering fast and accurate SARS-CoV-2 testing,” said Sebastian Kronmueller, Head of Molecular Diagnostics at Siemens Healthineers. “The Siemens Healthineers assay is designed to help researchers positively identify the virus in less than three hours so that healthcare professionals can proceed as quickly as possible with the necessary next steps on their patients’ triage paths.”

Luxembourg specialist in infectious disease detection kits

The test kit has been developed by Fast Track Diagnostics, a Siemens Healthineers Company located in Esch-sur-Alzette in the south of Luxembourg. Founded in 2007 as a spin-off of one of Luxembourg’s largest medical laboratories, Laboratoires Réunis, the company was acquired by Siemens Healthineers at the end of 2017.

Fast Track Diagnostics specialises in the design, development and manufacture of infectious disease detection kits that use syndromic multiplex real time PCR. FTD assays are validated on clinical samples and detect a comprehensive range of viruses, bacteria, fungi and parasites. They are in routine daily use in over 60 countries worldwide.

Pursuing emergency use approvals

The COVID-19 test kits are already being shipped within the European Union to be used for research only. The company is applying for Emergency Use Assessment and Listing from the World Health Organisation (WHO) for clinical use, as well as for Emergency Use Authorisation by the US Food and Drug Administration (FDA). At the same time, Siemens Healthineers is expanding its production capacity.

Read more

Luxembourg 7th most resilient economy in the world

28-05-2020

The ability of a country's business environment to withstand disruption and recover strongly is crucial for the individual companies that operate there. Luxembourg ranks as the 7th most resilient economy in the world, in particular due to its strong economy.
Read more

University of Luxembourg develops COVID-19 exit strategy simulator

26-05-2020

Experts at the University of Luxembourg have developed an online tool to simulate the impact of COVID-19 exit strategies. This unique project offers a method for modelling the impact of different measure on the spread of the disease in almost 100 countries around the world.
Read more

COVID-19: The impact on clean technologies

22-05-2020

Will the effects of the COVID-19 pandemic stimulate cleantech innovation and the uptake of environmentally friendly technologies, or will it bring cleantech investment to a standstill? This question was debated at the Cleantech Interactive session organised on 19-20 May 2020 in collaboration with Luxembourg partners.
Read more

15 innovative start-up projects to combat COVID-19

15-05-2020

15 Luxembourg start-ups will receive €150,000 each to develop innovative solutions aimed at combatting the effects of the COVID-19 pandemic crisis.
Read more

Coronavirus bailouts: Luxembourg among the most generous

12-05-2020

Many countries have launched rescue packages to help alleviate the economic consequences of the coronavirus-related lockdown. A recent article by the BBC lists Luxembourg's economic stabilisation programme as one of the most important in the world.
Read more

All news

Fermer